As of December 31, 2018, ~0.7 million patients (785,883) were being treated for end stage renal disease (ESRD) in the United States, giving a point prevalence of 2,382 per million population; prevalence of dialysis treatment was 1,685 per million, whereas prevalence of functioning kidney transplant was 696 per million.
The prevalence of ESRD more than tripled between 1990 and 2018.